PubMed Health⌕ Search

Biomedical subjects

P Thunberg

Publications and source records attributed to P Thunberg.

2 recordsLinked to original sources

Correction for acceleration-induced displacement artifacts in phase contrast imaging.

The acceleration-induced displacement artifact impairs the accuracy of MR velocity measurements. This study proposes a post processing method for correction of this artifact. Velocity measurements were performed in a flow phantom containing a constriction. Velocity curves were obtained from streamlines parallel to the frequency, phase, and slice directions, respectively. The acceleration-induced displacement artifact was most prominent when the frequency encoding direction was aligned with the flow direction. After correction, velocity assignment improved and a more accurate description of the flow was obtained. In vivo measurements were performed in the aorta in a patient with a repaired aortic coarctation. The correction method was applied to velocity data along a streamline parallel to the frequency encoding direction. The result after correction was a new location of the peak velocity and improved estimates of the velocity gradients.

Adult↗

Intraperitoneal interferon in the management of malignant ascites.

BACKGROUND: Ascites secondary to malignancy is a major cause of recurring morbidity in patients with ovarian cancer. In patients previously treated with cisplatin, other chemotherapeutic agents are not likely to be effective in relieving symptoms. METHODS: A pilot group of ten patients was treated with intraperitoneal alpha-2B-interferon (alpha-2B-IFN) in an effort to provide symptomatic relief of their ascites. All patients had advanced epithelial ovarian cancer at the time of therapy and were receiving treatment for palliation only. Symptoms included abdominal distention (100% of patients), nausea and vomiting in the absence of mechanical intestinal obstruction (60%), and dyspepsia (40%). RESULTS: At a dose of 10 M units/m2 given intraperitoneally every 2 weeks for one to four treatments, the toxicity was low, but the benefits were minimal. Five (50%) patients reported symptomatic improvement of 2-7 weeks' duration. The most common side effects included fever (temperature of more than 38.5 degrees C) and abdominal pain. CONCLUSIONS: At the dose of 10 M units/m2 of intraperitoneal alpha-2B-IFN, this regimen did not appear to produce clinically significant palliation of the ascites in most patients.

Adult↗